(Q45095062)

9 December 2017

title

Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension (English)

1 reference

9 December 2017

5

Mandeep R Mehra

1 reference

9 December 2017

Myung H Park

1

1 reference

9 December 2017

Robert L Scott

series ordinal

2

1 reference

9 December 2017

Patricia A Uber

series ordinal

3

1 reference

9 December 2017

Hector O Ventura

series ordinal

4

1 reference

9 December 2017

publication date

1 September 2004

1 reference

9 December 2017

published in

Congestive Heart Failure

1 reference

9 December 2017

volume

10

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

221-225

1 reference

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

Six-Minute Walk Distance in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03881.X

10.1111/J.1527-5299.2004.03881.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference